Neutralizing Antibodies
Showing 1 - 25 of 5,795
Hemophilia B Trial (CSL222 (AAV5-hFIXco-Padua))
Not yet recruiting
- Hemophilia B
- CSL222 (AAV5-hFIXco-Padua)
- (no location specified)
Aug 14, 2023
HIV-1-infection Trial in Pathum Wan (VRC07-523LS, PGDM1400LS, N-803)
Not yet recruiting
- HIV-1-infection
- VRC07-523LS
- +7 more
-
Pathum Wan, Bangkok, Thailand
- +1 more
Mar 8, 2023
Treatment of BK Virus Infection in Hematopoietic Stem Cell
Recruiting
- BK Virus Infection
-
Strasbourg, FranceService Laboratoire de Virologie - PTM - CHU de Strasbourg - Fra
Nov 8, 2022
Broadly HIV-1 Neutralizing Antibodies in HIV-infected Mbeya,
Active, not recruiting
- HIV/AIDS
-
Mbeya, TanzaniaNIMR-Mbeya Medical Research Center (MMRC)
Aug 5, 2022
Japanese Encephalitis, Vaccine Preventable Disease, Vaccine Reaction Trial in Lishui, Quzhou, Wenzhou (Japanese Encephalitis
Active, not recruiting
- Japanese Encephalitis
- +2 more
- Japanese Encephalitis Vaccine (Vero Cell), Inactivated;
- No prospective interventions
-
Lishui, Zhejiang, China
- +2 more
Nov 13, 2022
COVID-19 Trial in Beijing (SA55 Injection, Placebo for SA55 injection)
Recruiting
- COVID-19
- SA55 Injection
- Placebo for SA55 injection
-
Beijing, ChinaBeijing Ditan Hospital Capital Medical University
Sep 20, 2023
SARS-COV-2/COVID-19 Neutralizing Antibodies in Blood
Completed
- SARS-CoV2 Infection
-
Starkville, Mississippi
- +4 more
Aug 8, 2022
Antibodies and Immunity After Vaccination of Recovered COVID-19
Active, not recruiting
- Long COVID-19
-
Bangkok Noi, Bangkok, ThailandFaculty of Medicine Siriraj Hospital, Mahidol University
Aug 3, 2022
HIV Trial (Teropavimab, Zinlirvimab, Lenacapavir Tablet)
Not yet recruiting
- HIV Infections
- Teropavimab
- +4 more
- (no location specified)
Feb 6, 2023
COVID-19; Isolation of Neutralizing Antibodies for Therapeutics
Active, not recruiting
- SARS-CoV 2
- Blood sampling
-
Grenoble, FranceUniversityGrenobleHospital
Mar 24, 2022
COVID-19, SARS CoV 2 Infection Trial in Orléans (Collection of biological samples)
Not yet recruiting
- COVID-19
- SARS CoV 2 Infection
- Collection of biological samples
-
Orléans, FranceCentre Hospitalier Régional d'Orléans, France
Jul 21, 2022
HIV Infection Trial in United States (N-803 (IL-15 Superagonist), VRC07-523LS, 10-1074)
Recruiting
- HIV Infection
- N-803 (IL-15 Superagonist)
- +2 more
-
Los Angeles, California
- +11 more
Sep 22, 2022
Mucopolysaccharidosis (MPS), Hunter Syndrome Trial (ELAPRASE, Rituximab, Methotrexate)
Not yet recruiting
- Mucopolysaccharidosis (MPS)
- Hunter Syndrome
- ELAPRASE
- +3 more
- (no location specified)
Aug 8, 2022
Human Immunodeficiency Virus Trial in New York, Philadelphia (3BNC117-LS, 10-1074-LS, N803)
Not yet recruiting
- Human Immunodeficiency Virus
- 3BNC117-LS
- +2 more
-
New York, New York
- +2 more
Jul 12, 2022
"Persistence of Neutralizing Antibodies Against Yellow Fever in
Active, not recruiting
- HIV Infections
- Yellow Fever Vaccine
- Yellow fever neutralizing antibodies measure
-
Antwerp, Belgium
- +11 more
Aug 3, 2021
Coronavirus Infections Trial in Moscow (tixagevimab/cilgavimab 150+150 mg, tixagevimab/cilgavimab 300+300 mg, regdanvimab)
Active, not recruiting
- Coronavirus Infections
- tixagevimab/cilgavimab 150+150 mg
- +2 more
-
Moscow, Russian FederationMoscow City Clinical Hospital 52
Aug 7, 2023
HIV, HIV/AIDS, HIV-1 Infection Trial in Philadelphia (Pegylated Interferon alpha 2b (peg-IFN-a2b), 3BNC117 + 10-1074)
Unknown status
- HIV
- +2 more
- Pegylated Interferon alpha 2b (peg-IFN-α2b)
- 3BNC117 + 10-1074
-
Philadelphia, Pennsylvania
- +1 more
Jun 22, 2021
Vaccination Against COVID-19 in Patients PresentingNeuromuscular
Active, not recruiting
- Neuromuscular Diseases
- +2 more
- Blood sample for research of anti-xoprs netralizing anti spike
- Questionnaire
-
Bordeaux, FranceUniversity Hospital of Bordeaux
Apr 28, 2022
Hepatitis B Trial in Graz, Vienna (VVX001, Placebo)
Recruiting
- Hepatitis B
- VVX001
- Placebo
-
Graz, Austria
- +1 more
Apr 2, 2021
HIV-1-infection Trial in Brazil, United States (ChAdOx1.tHIVconsv1, ChAdOx1.HIVconsv62, MVA.tHIVconsv3)
Not yet recruiting
- HIV-1-infection
- ChAdOx1.tHIVconsv1
- +7 more
-
San Diego, California
- +11 more
Oct 4, 2023
HIV/AIDS Trial in San Francisco (Combination Intervention)
Active, not recruiting
- HIV/AIDS
- Combination Intervention
-
San Francisco, CaliforniaZuckerberg San Francisco General Hospital, University of Califor
Mar 21, 2022
TURN-COVID Biobank: The Dutch Cohort Study for Evaluation of Use
Recruiting
- COVID-19
- casirivimab with imdevimab
- +2 more
-
Amsterdam, Noord Holland, Netherlands
- +3 more
Jan 13, 2022